Health insurance coverage among cancer patients varies greatly by demographics and cancer type

April 27, 2015

A new analysis has found that, among patients with cancer, rates of health insurance coverage vary by patient demographics and by cancer type. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that the expansion of coverage through the Affordable Care Act may disproportionally benefit certain patient populations.

In the United States, an estimated 48 million individuals live without health insurance. To examine how insurance coverage differs among cancer patients according to various individual factors such as age, gender, and race, as well as according to different cancer types, Usama Mahmood, MD, an investigator at the University of Texas MD Anderson Cancer Center in Houston, and Stephen Grant, a medical student at Baylor College of Medicine, led a team that analyzed information from the Surveillance, Epidemiology, and End Results (SEER) database, which compiles incidence and survival data from population-based cancer registries in the United States. Their analysis included 688,794 patients age 18 to 64 years who were diagnosed with one of the top 25 cancers between 2007 and 2010.

The researchers found that younger, non-White, unmarried patients residing in counties with higher levels of poverty and in rural areas were less likely to have insurance. Moreover, males were less likely to have insurance than females, and people residing in Southern states were less likely to have insurance than people residing in other areas of the country. Also, there was large variation in insurance rates by cancer type, with the highest uninsured rates in testicular, stomach, and cervical cancers, and the lowest uninsured rates in thyroid, prostate, and breast cancers. Among all uninsured patients, however, the most prevalent cancers were lung cancer (which also resulted in the greatest number of cancer deaths), colorectal cancer, and breast cancer.

"To our knowledge, this is the first study that looks at variation in insurance status according to type of cancer," said Dr. Mahmood. "Both insurance status and type of cancer are affected by demographic factors, and it was interesting to see how each varies with the other." Dr. Mahmood added that the study provides insights into which subsets of cancer patients will likely benefit the most from the expansion of health care coverage under the Affordable Care Act. "Further research will be required to determine how changes in health care coverage impact the presentation, treatment, and survival of cancer patients," he said.
-end-


Wiley

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.